Condition
Chronic Plaque Psoriasis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Plaque Psoriasis clinical trials that are recruiting, at sites in 2 countries (most in Pakistan (1), United States (1)). By phase: Early Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Roflumilast 0.3% Cream for chronic plaque psoriasis and nail psoriasis
This study tests whether applying roflumilast 0.3% cream daily for 24 weeks helps people 12 years and older with chronic plaque psoriasis and moderate-to-severe nail psoriasis.
-
Apremilast versus methotrexate for moderate to severe plaque psoriasis
This test compares apremilast and methotrexate to see which works better for adults (18–60) with moderate to severe plaque psoriasis who have not had systemic therapy in the past 3 months.
Related topics
Quick answers
How many Chronic Plaque Psoriasis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Pakistan (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.